Research Expert: Sarah Overall
  • Published: Feb 2025
  • Pages: 150
  • SKU: IRTNTR43297

  • Latest News- Epinephrine Autoinjector Market: 0.30gm is expected to lead the Type segment during 2024-2028

    The Epinephrine Autoinjector Market is being driven by Increasing prevalence of allergies

    The Epinephrine Autoinjector Market is expected to grow at a CAGR of 10.59% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2.44 billion. The US epinephrine autoinjector market is poised for growth due to increasing pressure on the Food and Drug Administration (FDA) to approve more generic alternatives. With the recent price surge of Viatriss EpiPen, US authorities, such as Governor Margaret Wood Hassan, have urged the FDA to consider approving additional options. Companies like Bausch Health and ALK Abello, holding significant market shares in Europe, may capitalize on this initiative and enter the US market. For instance, Teva Pharmaceutical Industries launched the AJOVY in the prefilled YpsoMate 2 in March 2020. This government push for competition in the market is expected to lead to a substantial number of product launches during the forecast period. 

    Get more information on Epinephrine Autoinjector Market by requesting a sample report

    Which Factors Are Causing a Surge in Market Growth?

    The market is segmented based on

    • Type
      • 0.30gm
      • 0.15gm
      • 0.50gm
    • End-user
      • Hospitals
      • clinics
      • Homecare
    • Age Group
      • 0 to 6 Years
      • 6 to 12 Years
      • Over 12 Years
    • Geography
      • North America
        • US
      • Europe
        • Germany
        • UK
      • Asia
        • China
        • Japan
      • Rest of World (ROW)

      According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

      • Increasing prevalence of allergies
      • Rising innovations in marketing strategies by vendors
      • Rise in awareness of anaphylaxis and availability of innovative epinephrine autoinjectors

      However, the market also witnesses some limitations, which are as follows:

      • Product recalls and regulatory issues
      • High demand for substitutes of epinephrine autoinjectors in developing countries
      • High cost of epinephrine autoinjector

      Benefits of Buying Global Epinephrine Autoinjector Market Research Report by Technavio

      Rich Experience: 20+ years leading global market research, trusted insights across industries.

      Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

      Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

      Market Scope in Epinephrine Autoinjector Market Research Report

      Market Scope

      Report Coverage

      Details

      Page number

      154

      Base year

      2023

      Historic period

      2018-2022

      Forecast period

      2024-2028

      Growth momentum & CAGR

      Accelerate at a CAGR of 10.59%

      Market growth 2024-2028

      USD 2.44 billion

      Market structure

      market_structure.ucfirst

      YoY growth 2023-2024(%)

      8.78

      Key countries

      US, Germany, UK, China, and Japan

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      Find out which segment is leading the market by accessing the free PDF report

      Research Analysis Overview

      The Epinephrine Autoinjector market encompasses handheld devices like epinephrine pens and epipens, which deliver essential doses of epinephrine, also known as adrenaline, to individuals experiencing acute anaphylactic reactions due to allergic diseases, insect bites, or stings. These autoinjectors are crucial for severe allergic responses and are increasingly accepted by healthcare professionals and consumers. Companies like Amphastar Pharmaceuticals produce both branded and generic epinephrine autoinjectors, offering innovative needle-free injector technologies to cater to various age groups.

      Market Research Overview

      The Epinephrine Autoinjector market is a significant segment within the larger Global Healthcare Equipment Market, according to Technavio's market research. This market category encompasses businesses involved in the research and development (R&D), manufacturing, and distribution of epinephrine autoinjectors, which are essential medical devices used to treat acute anaphylactic reactions in various age groups suffering from allergic diseases. These injections are classified as consumables within the healthcare equipment industry, contributing to the overall market size, which includes the combined revenue generated by manufacturers of diagnostic equipment and devices across diverse therapy areas.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


      Contacts

      Technavio Research
      Jesse Maida
      Media & Marketing Executive
      US: +1 844 364 1100
      UK: +44 203 893 3200
      Email: media@technavio.com
      Website: www.technavio.com/

      Read News Read Less
      Interested in this report?
      Get your sample now!

    Safe and Secure SSL Encrypted

    Technavio

    • 2500 USD

    [5 reports/month/user]

    • 5000 USD

    close
    • Basic Plan [5000 USD/Year]:

      Single User
      Download 5 Reports/Month
      View 100 Reports/Month
      Add upto 3 Users at 625 USD/user

    • Teams Plan [7500 USD/Year]:

      5 User
      Download 5 Reports/Month/User
      View 100 Reports/Month/User
      Add upto 30 Users at 500 USD/user

    *You can upgrade to Teams plan at Subscription page

    close
    • Single:

      One user only.
      Quick & easy download option

    • Enterprise:

      Unlimited user access (Within your organization).
      Complimentary Customization Included

    *For Enterprise license, go to checkout page

    Technavio Get the report (PDF) sent to your email within minutes.